Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

1.

Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.

Nelson WW, Wang L, Baser O, Damaraju CV, Schein JR.

Int J Clin Pharm. 2014 Nov 27. [Epub ahead of print]

PMID:
25428444
[PubMed - as supplied by publisher]
2.

Hospital length of stay of nonvalvular atrial fibrillation patients who were administered Rivaroxaban versus Warfarin with and without pretreatment parenteral anticoagulants therapies.

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Hosp Pract (1995). 2014 Aug;42(3):17-25. doi: 10.3810/hp.2014.08.1114.

PMID:
25255403
[PubMed - in process]
3.

International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.

Nelson WW, Desai S, Damaraju CV, Lu L, Fields LE, Wildgoose P, Schein JR.

Curr Med Res Opin. 2014 Dec;30(12):2437-42. doi: 10.1185/03007995.2014.957822. Epub 2014 Sep 2.

PMID:
25170587
[PubMed - in process]
4.

Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation.

Nelson WW, Song X, Coleman CI, Thomson E, Smith DM, Damaraju CV, Schein JR.

Curr Med Res Opin. 2014 Dec;30(12):2461-9. doi: 10.1185/03007995.2014.933577. Epub 2014 Jun 25.

PMID:
24926732
[PubMed - in process]
5.

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Aug;30(8):1521-8. doi: 10.1185/03007995.2014.916159. Epub 2014 May 2.

PMID:
24758611
[PubMed - in process]
6.

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients.

Laliberté F, Cloutier M, Nelson WW, Coleman CI, Pilon D, Olson WH, Damaraju CV, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Jul;30(7):1317-25. doi: 10.1185/03007995.2014.907140. Epub 2014 Apr 2.

PMID:
24650301
[PubMed - in process]
7.

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation.

Choi JC, Dibonaventura MD, Kopenhafer L, Nelson WW.

Patient Prefer Adherence. 2014 Feb 7;8:167-77. doi: 10.2147/PPA.S56187. eCollection 2014.

PMID:
24532967
[PubMed]
Free PMC Article
8.

The economic burden to medicare of stroke events in atrial fibrillation populations with and without thromboprophylaxis.

Patel AA, Ogden K, Veerman M, Mody SH, Nelson WW, Neil N.

Popul Health Manag. 2014 Jun;17(3):159-65. doi: 10.1089/pop.2013.0056. Epub 2014 Jan 29.

PMID:
24476557
[PubMed - in process]
Free PMC Article
9.

Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P.

Curr Med Res Opin. 2014 Apr;30(4):645-53. doi: 10.1185/03007995.2013.867843. Epub 2013 Dec 5.

PMID:
24256067
[PubMed - indexed for MEDLINE]
10.

Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation.

Patel AA, Reardon G, Nelson WW, Philpot T, Neidecker MV.

Clin Ther. 2013 Nov;35(11):1794-804. doi: 10.1016/j.clinthera.2013.09.010. Epub 2013 Oct 15.

PMID:
24139051
[PubMed - indexed for MEDLINE]
11.

Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism.

Laliberté F, Bookhart BK, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS.

Patient. 2013;6(3):213-24. doi: 10.1007/s40271-013-0020-5.

PMID:
23857628
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillation.

Nelson WW, Choi JC, Vanderpoel J, Damaraju CV, Wildgoose P, Fields LE, Schein JR.

Am J Cardiol. 2013 Aug 15;112(4):509-12. doi: 10.1016/j.amjcard.2013.04.013. Epub 2013 Jun 22.

PMID:
23800552
[PubMed - indexed for MEDLINE]
Free Article
13.

Factors associated with warfarin discontinuation, including bleeding patterns, in atrial fibrillation patients.

Suh DC, Choi JC, Schein J, Kim S, Nelson WW.

Curr Med Res Opin. 2013 Jul;29(7):761-71. doi: 10.1185/03007995.2013.795142. Epub 2013 May 20.

PMID:
23581534
[PubMed - indexed for MEDLINE]
14.

Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding risk.

Reardon G, Nelson WW, Patel AA, Philpot T, Neidecker M.

Drugs Aging. 2013 Jun;30(6):417-28. doi: 10.1007/s40266-013-0067-y.

PMID:
23456440
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Usage of medications with high potential to interact with warfarin among atrial fibrillation residents in long-term care facilities.

Reardon G, Patel AA, Nelson WW, Philpot T, Neidecker M.

Expert Opin Pharmacother. 2013 Feb;14(2):165-73. doi: 10.1517/14656566.2013.747509. Epub 2012 Nov 30.

PMID:
23194153
[PubMed - indexed for MEDLINE]
16.

Burden of comorbidities among patients with atrial fibrillation.

LaMori JC, Mody SH, Gross HJ, daCosta DiBonaventura M, Patel AA, Schein JR, Nelson WW.

Ther Adv Cardiovasc Dis. 2013 Apr;7(2):53-62. doi: 10.1177/1753944712464101. Epub 2012 Oct 22.

PMID:
23090783
[PubMed - indexed for MEDLINE]
17.

Caregiver assistance among Medicare beneficiaries with atrial fibrillation and factors associated with anticoagulant treatment.

Chen SY, Vanderpoel J, Mody S, Nelson WW, Schein J, Rao P, Boulanger L.

Am J Geriatr Pharmacother. 2012 Oct;10(5):273-83. doi: 10.1016/j.amjopharm.2012.08.003. Epub 2012 Sep 12.

PMID:
22981404
[PubMed - indexed for MEDLINE]
18.

Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.

Laliberté F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS.

Adv Ther. 2012 Aug;29(8):675-90. doi: 10.1007/s12325-012-0040-x. Epub 2012 Aug 15.

PMID:
22898791
[PubMed - indexed for MEDLINE]
19.

Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation.

Patel AA, Lennert B, Macomson B, Nelson WW, Owens GM, Mody SH, Schein J.

Am Health Drug Benefits. 2012 Jul;5(5):291-8.

PMID:
24991327
[PubMed]
Free PMC Article
20.

Risk of hemorrhage and treatment costs associated with warfarin drug interactions in patients with atrial fibrillation.

Suh DC, Nelson WW, Choi JC, Choi I.

Clin Ther. 2012 Jul;34(7):1569-82. doi: 10.1016/j.clinthera.2012.05.008. Epub 2012 Jun 19.

PMID:
22717419
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk